ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176503; 2) Community: the network communities that were significantly associated with the response to NSC 176503; 3) Molecule: the relationships between components within communities and NSC 176503; 4) MDR: the compounds that were significantly associated with the NSC 176503.

NSC Compound Enrichment Correlation
NSC 613011 Latrunculin A 0.00888636978630782 -0.12535841
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.00888636978630782 0.65077658
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.00888636978630782 0.6432287
NSC 624172 Null 0.00888636978630782 0.52393743
NSC 629868 Null 0.00888636978630782 -0.097234676
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.00888636978630782 0.43735529
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.00888636978630782 0.6709097
NSC 645330 11H-Benzo[a]carbazole-1,4-dione, 7,11-dimethyl- 0.00888636978630782 0.68391634
NSC 657561 (Z)-4-bromo-4-iodo-3-phenyl-3-buten-2-one 0.00888636978630782 0.61692845
NSC 666707 2-bishydroxyimino-4-(4-morpholinyl)-1-phenylmethyl bicyclo[2.2.2]octane 0.00888636978630782 -0.012832162
Total:176  Current:49    [First] [Prev] [Next] [Last]